Foghorn Therapeutics appoints Stephen J. DiPalma as interim CFO and Treasurer, effective Jan 16, 2024

Foghorn Therapeutics Inc.

Stephen J. DiPalma appointed as Treasurer and interim CFO, effective immediately.
Company continues search for a permanent CFO; DiPalma is a managing director at Danforth Advisors.
Foghorn will pay Danforth an agreed hourly rate plus expenses for DiPalma's interim CFO services.
DiPalma has served as CFO to multiple public and private life sciences companies.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Stephen J. DiPalma

Treasurer and interim Chief Financial Officer

FHTX · Foghorn Therapeutics Inc.

Effective: 2024-01-16
Filed: January 17, 2024, 6:59 PM ET

On January 16, 2024, the Board of Directors of Foghorn Therapeutics Inc. (the “Company”) appointed Stephen J. DiPalma as Treasurer and interim Chief Financial Officer (“CFO”), effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Stephen J. DiPalma was appointed as Treasurer and interim Chief Financial Officer at Foghorn Therapeutics Inc..

Action: appointed
Role: Treasurer and interim Chief Financial Officer

Exact text from the filing

On January 16, 2024, the Board of Directors of Foghorn Therapeutics Inc. (the “Company”) appointed Stephen J. DiPalma as Treasurer and interim Chief Financial Officer (“CFO”), effective immediately.

View on SEC.gov

Foghorn Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001628280-24-001504

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.